Discovery of Gene May Provide Treatment for Nearsightedness

Author:Duke University Medical Center
Published: 2010/09/12 -Updated: 2025/06/02
Publication Details: Peer-Reviewed, Findings
Category Topic:Blindness and Vision Loss -Publications List

Page Content:Synopsis -Introduction -Main -Insights, Updates

Synopsis: This article, published in the peer-reviewed journal Nature Genetics, details a major advance in understanding the genetic basis of myopia (nearsightedness), the world's most common eye disorder. Researchers from Duke University Medical Center and international collaborators identified a gene, RASGRF1, strongly associated with myopia in Caucasian populations, with findings validated across more than 13,000 subjects from diverse regions. The study underscores the potential for gene therapy in treating myopia, a condition that can lead to serious complications such as retinal detachment and blindness, especially for the 2-3% of cases classified as pathological.

The article is particularly helpful for seniors, people with disabilities, and caregivers, as it highlights both the genetic risks and the importance of lifestyle factors - such as spending time outdoors and looking into the distance - to help manage or potentially reduce the risk of myopia progression. The research also points to the accessibility of the eye for noninvasive monitoring and intervention, making future therapies more feasible for those with limited mobility or additional health challenges -Disabled World (DW).

Introduction

Myopia (nearsightedness) is the most common eye disorder in the world and becoming more common, yet little is known about its genetic underpinnings.

Scientists at Duke University Medical Center, in conjunction with several other groups, have uncovered a gene associated with myopia in Caucasian people from several different regions, including Dutch, British and Australian subjects. Their work was published inNature Genetics online on Sunday, Sept. 12.

Main Content

Myopia happens when the focal point of an image falls just short of the retina at the rear of the eye, causing blurred distance vision.

Often the discovery of a gene still means that many years could pass before a treatment becomes available. However, gene therapies are already working well in some eye conditions, and myopia may be a good candidate condition for gene repair.

"The eye is already an organ of choice for gene therapy, for example, because the eye's small volume and self-contained area allow the therapy to remain inside the eye in a concentrated volume," said lead author Terri Young, M.D., professor of ophthalmology, pediatrics, and medicine, and a researcher in the Center for Human Genetics at Duke. "In addition, the eye's accessibility lets clinicians observe the effects of treatment over time with noninvasive methods that can illuminate and test the retina and other eye structures."

While many cases of myopia are mild, about 2 to 3 percent are pathological cases with retinal detachment, premature glaucoma, macular bleeding, and glaucoma leading eventually to blindness, said Young, who has spent over a decade studying the severe form of myopia.

Up to 80 percent of people in Singapore have myopia, while about one in three Americans has the condition. Countries with a high prevalence of nearsightedness have a hard time finding fighter pilots, to give one example of how myopia affects a population.

Looking Into the Distance Helps Myopia

"People need to go outside and look to the horizon," Young said. "Today's near work forces our eyes to constantly be in tension to focus on near objects - reading papers and watching monitors. We also watch TV, work in cities with high buildings, drive in heavy traffic, and generally have fewer chances for distant views, especially in urban areas. These factors affect children with developing vision, as well as many adults."

Working with a large group of researchers, Young, co-lead author Pirro Hysi of the Department of Twin Research and Genetic Epidemiology of Kings College in London, and colleagues found several distinct spellings of DNA code near the RASGRF1 gene that had a strong association with focusing errors in vision. These findings were validated in six other Caucasian adult groups in a total of 13,414 subjects.

"Because RASGRF1 is highly expressed in neurons and the retina, it is crucial to retinal function and visual memory consolidation," Young said.

When the scientists created mice that were missing the correct gene, these mice showed changes in their eye lenses.

"This was biologically convincing," Young said. "The RASGRF1 provides a novel molecular mechanism to study so that we can work to prevent the most common cause of visual impairment."

Young has also led a team that found a different gene - CTNDD2 - related to myopia in Chinese and Japanese populations. That work included researchers from the Duke Center for Human Genetics, the Duke-National University of Singapore (NUS) Graduate Medical School in Singapore, and the National University of Singapore. In many Asian countries, a majority of people have myopia.

Funding

The National Institutes of Health (NIH) National Eye Institute, the NIH Center for Inherited Disease Research, the Wellcome Trust, the EU MyEuropia Marie Curie Research Training Network, and Guide Dogs for the Blind Association, the European Community's Seventh Framework Program /grant agreement, the ENGAGE project grant agreement and the FP-5 GenomEUtwin Project.

The study also received support from the National Institute for Health Research (NIHR) comprehensive Biomedical Research Center award to Guy's & St Thomas' NHS Foundation Trust, in partnership with King's College, London.

The project received support from a Biotechnology and Biological Sciences Research Council project grant.

Other Authors Include:

Scientists from the Lions Eye Institute, University of Western Australia, Center for Ophthalmology and Visual Science in Perth, Australia; the Center for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital in Australia; the University of Salamanca, CIC-IBMCC (CSIC-USAL) in Salamanca, Spain; the Departments of Ophthalmology and Epidemiology, Erasmus Medical Center, in Rotterdam, the Netherlands; Genetics and Population Health, Queensland Institute of Medical Research, in Brisbane, Australia; the Department of Psychiatry, University of Hong Kong, China; and the MRC Center of Epidemiology for Child Health, Institute of Child Health, University College in London.

Insights, Analysis, and Developments

Attribution/Source(s): This peer reviewed publication was selected for publishing by the editors of Disabled World (DW) due to its relevance to the disability community. Originally authored byDuke University Medical Center and published on 2010/09/12, this content may have been edited for style, clarity, or brevity.NOTE: Disabled World does not provide any warranties or endorsements related to this article.